Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

48.50
Delayed Data
As of Apr 20
 -0.35 / -0.72%
Today’s Change
29.95
Today|||52-Week Range
50.05
+21.71%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Schwabe Stefan K F
Executive Vice President-Research & Development
Sale9/07/201795,000$46.58$4.4M+1.46%
Vaughn Victor L
Senior Vice President-Sales
Sale1/02/201855,000$40.11$2.2M+19.90%
Patrick Gregory S
Chief Financial Officer & Vice President
Sale1/11/201850,000$43.56$2.2M+8.38%
Patrick Gregory S
Chief Financial Officer & Vice President
Sale4/24/201754,000$32.37$1.7M+49.69%
Schwabe Stefan K F
Executive Vice President-Research & Development
Buy9/07/201795,000$12.92$1.2M+1.46%
Vaughn Victor L
Senior Vice President-Sales & Marketing
Sale4/05/201826,250$45.33$1.2M+7.06%
Patrick Gregory S
Chief Financial Officer & Vice President
Sale9/07/201725,000$46.36$1.2M+1.46%
Patrick Gregory S
Chief Financial Officer & Vice President
Sale9/08/201723,481$48.89$1.1M-0.21%
Bhatt Padmanabh P
Sale1/22/201820,000$48.04$960.8K+9.60%
Bhatt Padmanabh P
Sale1/17/201820,000$44.98$899.6K+4.30%
Page of 6